Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v2.4.0.6
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Dec. 31, 2012
Dec. 31, 2011
Current assets    
Cash and cash equivalents $ 27,361 [1] $ 71,516
Accounts receivable, net 21,162 [1] 12,544
Inventory, net 22,261 [1] 13,339
Prepaid expenses and other current assets 7,873 [1] 2,179
Current assets of discontinued operations   4
Total current assets 78,657 [1] 99,582
Property, plant, equipment, and investment properties, net 16,526 [1] 5,358
Intangible assets, net 95,784 [1] 76,730
Goodwill 80,450 [1] 39,815
Investments, net 15,636 [1] 6,717
Other assets 2,777 [1] 1,287
Total assets 289,830 [1] 229,489
Current liabilities    
Accounts payable 10,200 [1] 4,891
Accrued expenses 24,656 [1] 4,956
Current portion of lines of credit and notes payable 17,526 [1] 8,757
Current liabilities of discontinued operations    174
Total current liabilities 52,382 [1] 18,778
Other long-term liabilities, principally contingent consideration and deferred tax liabilities 34,168 [1] 25,443
Total liabilities 86,550 [1] 44,221
Commitments and contingencies    [1]   
Series D Preferred Stock - $0.01 par value, 2,000,000 shares authorized; 1,129,032 and 1,129,032 shares issued and outstanding (liquidation value of $30,595 and $28,355) at December 31, 2012 and 2011, respectively 24,386 [1] 24,386
Equity    
Common Stock - $0.01 par value, 500,000,000 shares authorized; 305,560,763 shares and 297,503,033 shares issued and outstanding at December 31, 2012 and 2011, respectively 3,056 [1] 2,975
Treasury stock (2,293,056 shares and 2,488,477 shares at December 31, 2012 and 2011, respectively) (7,457) [1] (8,092)
Additional paid-in capital 565,201 [1] 524,814
Accumulated other comprehensive income 7,356 [1] 907
Accumulated deficit (388,770) [1] (359,722)
Total shareholders' equity 179,386 [1] 160,882
Noncontrolling interests (492) [1]  
Total equity 178,894 [1]  
Total liabilities, Series D Preferred Stock and equity 289,830 [1] 229,489
Series A Preferred Stock
   
Equity    
Preferred Stock    [1]   
Series C Preferred Stock
   
Equity    
Preferred Stock    [1]   
[1] As of December 31, 2012, total assets include $5.6 million and total liabilities include $5.5 million related to SciGen (I.L.) Ltd, ("SciGen"), a consolidated variable interest entity. SciGen's consolidated assets are owned by SciGen and SciGen's consolidated liabilities are those as to which there is no recourse against us. Refer to Note 3.